Image

Blood Glucose Management in Intensive Care Units

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The investigators propose to conduct a study of practices to describe the methods of managing glycemic control in hospitalized patients in critical care. This is a prospective multicenter observational study conducted in Intensive Medicine and Resuscitation departments in France and Belgium. The aim of this study is to carry out an inventory of the current practices of glycemia management as well as their modalities. Being one of the key points of the management, this work will have for main objective to raise the importance of the glycemic variabilities according to the methods of insulin therapies used.

Eligibility

Inclusion Criteria:

  • Patient with hyperglycaemia requiring an insulin prescription within 48 hours of admission
  • Insulin therapy started less than 12 hours before inclusion of the patient in the study
  • Expected duration of hospitalization greater than or equal to 48 hours

Exclusion Criteria:

  • Moribund patients
  • Patients admitted for ketoacidosis or hyperosmolar coma
  • Patients admitted for symptomatic hypoglycaemia
  • Patient requiring insulin for serum potassium correction
  • Severe acute hepatocellular insufficiency
  • Age < 18 years old
  • Pregnant or breastfeeding women
  • Patients under legal protection measures

Study details

Insulin Hypoglycemia, Glucose Test Site Bleeding, Hyperglycemia

NCT05775770

French Society for Intensive Care

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.